relationrx

Senior Machine Learning Research Engineer

relationrx
Apply
2 months ago
London, United KingdomSenior

Responsibilities

  • Implement and optimize large neural network models and scalable training pipelines.
  • Profile and optimize compute, memory, and I/O performance across GPU workloads.
  • Design and implement distributed training across multi-GPU and multi-node configurations.
  • Build and maintain core ML infrastructure for training, evaluation, inference, and deployment.
  • Partner with ML Scientists to translate research into reproducible, production-grade systems.
  • Contribute to architectural and algorithmic decisions and resolve numerical, performance, and reliability issues.
  • Establish engineering practices for research code and track relevant advances in ML systems.

Requirements

  • Degree in Computer Science, Engineering, Physics, or a related quantitative discipline.
  • Industry experience as an ML or research engineer working on large neural network training.
  • Strong software engineering fundamentals in Python and deep expertise in PyTorch or equivalent modern ML frameworks.
  • Hands-on experience training large neural networks at scale, including distributed training frameworks.
  • Demonstrable experience profiling and optimizing GPU workloads.
  • Working knowledge of cloud-based ML infrastructure and containerized environments.
  • Experience turning research code from prototypes into robust, reusable infrastructure.
  • Bonus: CUDA or Triton kernel development, FlashAttention-style attention implementations, foundation models for biology, vision, or language, or contributions to open-source ML frameworks.

Tech Stack

Categories

AI ResearchML Engineering
relationrx

About relationrx

51-200 employees

Relation is a privately held biotech that discovers and develops medicines using single-cell and multi-omics data from patient tissues combined with machine learning. Its in-house wet and dry labs form an end-to-end platform to identify drug targets and progress programs toward the clinic, including potential biopharma partnerships. Founded in 2019 and headquartered in London, the company raised a seed round in 2024.

Contact me